Research Article
Metabolic Phenotype and Adipose Tissue Inflammation in Patients with Chronic Obstructive Pulmonary Disease
Table 2
Characteristics of the respective components of the metabolic syndrome in COPD patients.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Values are given as No (%). *Central obesity: waist circumference > 94 cm (men) or >80 cm (women); raised blood pressure: systolic BP ≥ 130 mm Hg or diastolic BP ≥ 85 mm Hg, or treatment of previously diagnosed hypertension; raised triglycerides: >150 mg·dL−1 or specific treatment; reduced HDL cholesterol < 40 mg·dL−1 (men) or <50 mg·dL−1 (women), or specific treatment; raised fasting plasma glucose > 100 mg·dL−1 or specific treatment. HDL: high density lipoprotein; BMI: body mass index. |